openPR Logo
Press release

Eye Allergy Therapeutics Industry to Achieve $4.10 Billion Growth by 2029

08-25-2025 01:55 PM CET | Health & Medicine

Press release from: The Business Research Company

Eye Allergy Therapeutics Market

Eye Allergy Therapeutics Market

Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.

How Will the Eye Allergy Therapeutics Market Grow by 2025 in Terms of Size and Growth?
Over recent years, the market size for eye allergy therapeutics has seen significant growth. The market is anticipated to expand from $3.04 billion in 2024 to a valuation of $3.23 billion in 2025, marking 6.4% compound annual growth rate (CAGR). The historic growth phase can be linked to factors such as a rise in cases of allergic conjunctivitis, increased awareness about eye allergies, heightened levels of urban pollution, wider availability of advanced therapeutic solutions, and improvements made in healthcare infrastructure.

What Are the Estimated Growth Rates for the Eye Allergy Therapeutics Industry Through 2029?
The market for eye allergy therapeutics is predicted to experience significant expansion in the approaching years, ballooning to a valuation of $4.10 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. Several factors are poised to contribute to this market momentum during the forecast period, including an aging demographic, the escalating use of biologics, a surge in ophthalmic research funding, broadening public awareness around symptoms of eye allergies, and advancements in medication delivery technologies. The period is also anticipated to witness key trends such as advancements in personalized medicine, innovative sustained-release formulations, digital diagnostics integration, progress in biologic therapies, and new non-invasive treatment methodologies.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/eye-allergy-therapeutics-global-market-report

What Are the Strategic Drivers Boosting Eye Allergy Therapeutics Market Performance?
The escalation in eye allergy incidences is anticipated to drive the expansion of the eye allergy therapeutics market. Eye allergies constitute immune system responses that result in the inflammation and discomfort of eyes due to allergens. The escalating frequency of such allergies corresponds to the increasing environmental pollution, which exposes people to a higher quantity of airborne allergens, consequently initiating a surge in allergic reactions. Therapeutics for eye allergies work to manage these allergies by mitigating inflammation, alleviating itchiness and redness, and obstructing allergic reactions to provide efficient relief from symptoms. For example, data from the National Library of Medicine, a biomedical library based in the US, from May 2025 showed ocular allergy (OA) impacted 49.3% (n=207) of cases and that seasonal allergic conjunctivitis (SAC) constituted 90.3%, primarily affecting 14-year-olds (23.4%) and females (58.8%). Hence, the burgeoning frequency of eye allergies is fuelling the expansion of the eye allergy therapeutics market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25765&type=smp

What Are the Segments in the Eye Allergy Therapeutics Market?
The eye allergy therapeutics market covered in this report is segmented -

1) By Drug Class: Antihistamines, Mast Cell Stabilizers, Dual-Action Agents, Corticosteroids, Decongestants, Immunotherapy, Other Drug Classes
2) By Allergy Type: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC), Giant Papillary Conjunctivitis
3) By Route of Administration: Topical, Oral, Injectable, Ocular, Systemic
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Channels
5) By End User: Hospitals, Clinics, Homecare Settings, Pharmacies, Research Institutions

Subsegments:

1) By Antihistamines: Olopatadine, ket*otifen, Emedastine, Levocabastine, Bepotastine
2) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil, Lodoxamide, Pemirolast
3) By Dual-action Agents: Olopatadine, ket*otifen Fumarate, Azelastine, Alcaftadine
4) By Corticosteroids: Loteprednol Etabonate, Prednisolone Acetate, Dexamethasone, Fluorometholone
5) By Decongestants: Naphazoline, Tetrahydrozoline, Oxymetazoline, Phenylephrine
6) By Immunotherapy: Subcutaneous Immunotherapy, Sublingual Immunotherapy, Allergen-specific Desensitization Drops
7) By Other Drug Classes: Nonsteroidal Anti-inflammatory Drugs, Biologics

What Are the Key Adoption Trends in the Eye Allergy Therapeutics Market?
Principal companies in the eye allergy therapeutics market are concentrating on developing groundbreaking solutions like eye allergy itch relief therapies. These are intended to provide swift symptom relief, increase patient comfort, and extend their reach through over-the-counter availability. These treatments are specifically crafted to soothe itching instigated by allergic reactions in the eyes. For example, in August 2024, Glenmark Pharmaceuticals Limited, a pharmaceutical company based in India, introduced the Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), with the goal of alleviating eye allergy symptoms. The twice-daily formulation offers quick and enduring relief from allergic conjunctivitis symptoms, including itching, redness, and watery eyes. The product's availability over-the-counter caters to the rising demand for self-care solutions and enables broader consumer accessibility in the eye care market.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25765&type=smp

Which Companies Lead the Competitive Landscape of the Eye Allergy Therapeutics Industry?
Major companies operating in the eye allergy therapeutics market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals plc, Santen Pharmaceutical Co. Ltd., Zydus Lifesciences Limited, Stallergenes Greer Ltd., HAL Allergy B.V., Ocular Therapeutix Inc., Tarsus Pharmaceuticals Inc., Nicox S.A.

Where Are the Key Eye Allergy Therapeutics Market Opportunities by Region?
North America was the largest region in the eye allergy therapeutics market in 2024. The regions covered in the eye allergy therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Eye Allergy Therapeutics Industry to Achieve $4.10 Billion Growth by 2029 here

News-ID: 4158277 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Allergy

Allergy Shots Market | ALK Abello, Aimmune Therapeutics, Allergy Therapeutics, A …
The global allergy shots market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the allergy shots market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Allergy Shots Market: Rising Demand and Advancements in Allergy Treatment
Market Overview: The Allergy Shots market refers to the production, distribution, and utilization of immunotherapy treatments known as allergy shots or allergen immunotherapy. Allergy shots are a form of treatment for allergies, particularly for allergic rhinitis (hay fever), allergic asthma, and insect sting allergies. They involve the administration of gradually increasing doses of allergens, such as pollen, dust mites, pet dander, or insect venom, to desensitize the immune system and
Allergy Treatment Market Increasing Demand By Allergy Type: Eye Allergy, Rhiniti …
Acumen Research and Consulting has announced the addition of the "Allergy Treatment Market” report to their offering. The Allergy Treatment Market Report 2018 is an in depth study analyzing the current state of the Allergy Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Allergy Treatment Market provides analysis of China market covering the industry trends, recent
Allergy Immunotherapy Market to Witness Huge Growth by Key Players: Allergy Ther …
According to a recent research study "Allergy Immunotherapy Market, by immunotherapy Type (SCIT, SLIT), By Type of Allergy (Asthma, Food Allergy, Allergic Rhinitis and Others) opportunities and forecast 2020-2026" published by Data Library Research, the Allergy Immunotherapy Market Studies many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key
Allergy Treatment Market Report 2018: Segmentation by Allergy Type (Food Allergy …
Global Allergy Treatment market research report provides company profile for Meda Pharmaceuticals Inc., Allergy Therapeutics, Sunovion Pharmaceuticals Inc., Allergon AB, Allergan, HAL Allergy Group, Teva Pharmaceutical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Allergy Treatment Global Market 2018: Key Players – ALK, Stallergenes Greer, A …
Allergy Treatment Industry Description Wiseguyreports.Com Adds “Allergy Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global Allergy Treatment market, analyzes and researches the Allergy Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like  ALK  Stallergenes Greer  Allergy Therapeutics  HAL Allergy Group  Circassia  GlaxoSmithKline plc  Sunovion Pharmaceuticals  Teva Pharmaceutical Industries  Allergan plc  Allergon